US Patent 7410780 IL-21 antagonists
Patent 7410780 was granted and assigned to ZymoGenetics on August, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
James W. West0
Julia E. Novak0
Scott R. Presnell0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+358 characters)
Article
Patent abstract
The polypeptides, and the polynucleotides encoding for them, described herein are IL-21 antagonists that bind with specificity and exhibit an EC50 that is not detectable in receptor binding studies. These molecules have mutations in the D helix of the IL-21 molecule, and can be used to inhibit the activity of IL-21 with its cognate receptor.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07410780 IL-21 antagonists US Patent 7410780 IL-21 antagonists
Infobox
Patent Number
074107800
Patent Number
74107800
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074107800
Date of Patent
August 12, 2008
0Patent Application Number
115395540
Date Filed
October 6, 2006
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07410780 IL-21 antagonists
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07410780
Date of patent
August 12, 2008
Patent application number
11539554
Date Filed
October 6, 2006
Patent primary examiner
Find more entities like US Patent 7410780 IL-21 antagonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.